Physician profile
Christopher Robison
NPI 1295148609
$4,140.38
in general payments reported to CMS, 2019-2025
11 companies · $399 in 2025
The $399 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,642 · 2020: $44.21 · 2021: $232 · 2022: $1,580 · 2023: $224 · 2024: $19.81 · 2025: $399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $542 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $542.13 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,582.15 | 2021-2023 | Urolift |
| Boston Scientific Corporation | $1,558.38 | 2019-2022 | |
| Janssen Biotech, INC. | $259.23 | 2025 | Erleada, Carvykti, Rybrevant |
| Abbvie INC. | $213.34 | 2023-2025 | Botox |
| Astellas Pharma US INC | $141.49 | 2020-2022 | |
| Neotract INC. | $135.32 | 2019 | |
| Allergan, INC. | $95.62 | 2019 | |
| Sumitomo Pharma America, INC. | $87.69 | 2023 | Orgovyx |
| Coloplast Corp | $33.16 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $19.81 | 2024 | Bard Urinary Drainage Bag |
| Amgen INC. | $14.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Robison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.